Blocking FGF2 with a new specific monoclonal antibody impairs angiogenesis and experimental metastatic melanoma, suggesting a potential role in adjuvant settings (2016)
- Authors:
- USP affiliated authors: CHAMMAS, ROGER - FM ; BUCHPIGUEL, CARLOS ALBERTO - FM
- Unidade: FM
- DOI: 10.1016/j.canlet.2015.11.030
- Subjects: METÁSTASE NEOPLÁSICA; MELANOMA ANIMAL; ANTICORPOS MONOCLONAIS
- Language: Inglês
- Imprenta:
- Source:
- Título: Cancer Letters
- ISSN: 0304-3835
- Volume/Número/Paginação/Ano: v. 371, n. 2, p. 151–160, 2016
- Status:
- Artigo possui versão em acesso aberto em repositório (Green Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
AGUIAR, Rodrigo Barbosa de et al. Blocking FGF2 with a new specific monoclonal antibody impairs angiogenesis and experimental metastatic melanoma, suggesting a potential role in adjuvant settings. Cancer Letters, v. 371, n. 2, p. 151–160, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.canlet.2015.11.030. Acesso em: 02 abr. 2026. -
APA
Aguiar, R. B. de, Parise, C. B., Souza, C. R. T., Braggion, C., Quintilio, W., Moro, A. M., et al. (2016). Blocking FGF2 with a new specific monoclonal antibody impairs angiogenesis and experimental metastatic melanoma, suggesting a potential role in adjuvant settings. Cancer Letters, 371( 2), 151–160. doi:10.1016/j.canlet.2015.11.030 -
NLM
Aguiar RB de, Parise CB, Souza CRT, Braggion C, Quintilio W, Moro AM, Marques FLN, Buchpiguel CA, Chammas R, Moraes JZ de. Blocking FGF2 with a new specific monoclonal antibody impairs angiogenesis and experimental metastatic melanoma, suggesting a potential role in adjuvant settings [Internet]. Cancer Letters. 2016 ; 371( 2): 151–160.[citado 2026 abr. 02 ] Available from: https://doi.org/10.1016/j.canlet.2015.11.030 -
Vancouver
Aguiar RB de, Parise CB, Souza CRT, Braggion C, Quintilio W, Moro AM, Marques FLN, Buchpiguel CA, Chammas R, Moraes JZ de. Blocking FGF2 with a new specific monoclonal antibody impairs angiogenesis and experimental metastatic melanoma, suggesting a potential role in adjuvant settings [Internet]. Cancer Letters. 2016 ; 371( 2): 151–160.[citado 2026 abr. 02 ] Available from: https://doi.org/10.1016/j.canlet.2015.11.030 - Assessment of the animal biodistribution of seven glucose appended [99mTc] technetium complexes in a murine melanoma tumor model
- Comparisson of 99mTc-DMSA-V, 99mTc-MIBI and [18F]FDG for melanoma detection
- Binding affinity, specificity and comparative biodistribution of the Parental Murine Monoclonal Antibody MX35 (Anti-NaPi2b) and its humanized version Rebmab200
- Binding Affinity, Specificity and Comparative Biodistribution of the Parental Murine Monoclonal Antibody MX35 (Anti-NaPi2b) and Its Humanized Version Rebmab200
- Comparison of 99mTc DMSA-V, 99mTc-MIBI and [18F] FDG for melanoma detection in cell expressing P-glicoprotein
- Neonatal seizures: The overlap between diagnosis of metabolic disorders and structural abnormalites
- Bradykinin-dependent pathways are activated within tumor microenvironments new targets for therapy
- Hedgehog signaling pathway mediates tongue tumorigenesis in wild-type mice but non Gal3: Deficient mice
- Use of RNA interference to investigate ADAM23 function and its role breast cancer progression
- F-18-Fluoride PET/CT and Tc-99m-MDP SPECT/CT can detect bone cancer at early stage in rodents
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
